137 related articles for article (PubMed ID: 11936730)
41. Urokinase therapy in neonates with catheter related central venous thrombosis.
Wever ML; Liem KD; Geven WB; Tanke RB
Thromb Haemost; 1995 Feb; 73(2):180-5. PubMed ID: 7792727
[TBL] [Abstract][Full Text] [Related]
42. Dose-ranging trial with a recombinant urokinase (urokinase alfa) for occluded central venous catheters in oncology patients.
Deitcher SR; Fraschini G; Himmelfarb J; Schuman E; Smith TJ; Schulz GA; Firszt CM; Mouginis TL
J Vasc Interv Radiol; 2004 Jun; 15(6):575-80. PubMed ID: 15178717
[TBL] [Abstract][Full Text] [Related]
43. Role of hydrochloric acid in the treatment of central venous catheter infections in children with cancer.
Barbaric D; Curtin J; Pearson L; Shaw PJ
Cancer; 2004 Oct; 101(8):1866-72. PubMed ID: 15386305
[TBL] [Abstract][Full Text] [Related]
44. The clotted central vein catheter for haemodialysis.
Twardowski ZJ
Nephrol Dial Transplant; 1998 Sep; 13(9):2203-6. PubMed ID: 9761497
[No Abstract] [Full Text] [Related]
45. [Venous thromboembolism associated with long-term use of central venous catheters in cancer patients].
Debourdeau P; Chahmi DK; Zammit C; Farge-Bancel D
Pathol Biol (Paris); 2008 Jun; 56(4):211-9. PubMed ID: 18395994
[TBL] [Abstract][Full Text] [Related]
46. [Management of central venous catheter: prevention of thrombosis and bacteremia].
Lomonte C; Basile C
G Ital Nefrol; 2009; 26(1):73-80. PubMed ID: 19255966
[TBL] [Abstract][Full Text] [Related]
47. Systemic anticoagulant prophylaxis for central catheter-associated venous thrombosis in cancer patients.
Chan A; Iannucci A; Dager WE
Ann Pharmacother; 2007 Apr; 41(4):635-41. PubMed ID: 17355999
[TBL] [Abstract][Full Text] [Related]
48. Persistent catheter-related bacteremia: clearance with antibiotics and urokinase.
Ascher DP; Shoupe BA; Maybee D; Fischer GW
J Pediatr Surg; 1993 Apr; 28(4):627-9. PubMed ID: 8483081
[TBL] [Abstract][Full Text] [Related]
49. Urokinase in the treatment of bacteremia and candidemia in patients with right atrial catheters.
Jones GR; Konsler GK; Dunaway RP
Am J Infect Control; 1996 Jun; 24(3):160-6. PubMed ID: 8806991
[TBL] [Abstract][Full Text] [Related]
50. Prospective study of arterial and central venous catheter colonization and of arterial- and central venous catheter-related bacteremia in intensive care units.
Traoré O; Liotier J; Souweine B
Crit Care Med; 2005 Jun; 33(6):1276-80. PubMed ID: 15942344
[TBL] [Abstract][Full Text] [Related]
51. A crossover randomized prospective pilot study evaluating a central venous catheter team in reducing catheter-related bloodstream infections in pediatric oncology patients.
Secola R; Azen C; Lewis MA; Pike N; Needleman J; Sposto R; Doering L
J Pediatr Oncol Nurs; 2012; 29(6):307-15. PubMed ID: 23087249
[TBL] [Abstract][Full Text] [Related]
52. Effectiveness of low dose urokinase on dialysis catheter thrombolysis.
Seddon PA; Hrinya MK; Gaynord MA; Lion CM; Mangold BM; Bruns FJ
ASAIO J; 1998; 44(5):M559-61. PubMed ID: 9804494
[TBL] [Abstract][Full Text] [Related]
53. [Microbiological findings in children with an indwelling central venous catheter].
Uher M; Pisarcíková M; Kurák M; Cernáková A; Takácová V; Molokácová M
Klin Mikrobiol Infekc Lek; 2004 Dec; 10(6):259-64. PubMed ID: 15655722
[TBL] [Abstract][Full Text] [Related]
54. Prospective, randomized trial of two different modalities of flushing central venous catheters in pediatric patients with cancer.
Cesaro S; Tridello G; Cavaliere M; Magagna L; Gavin P; Cusinato R; Zadra N; Franco Zanon G; Zanesco L; Carli M
J Clin Oncol; 2009 Apr; 27(12):2059-65. PubMed ID: 19273702
[TBL] [Abstract][Full Text] [Related]
55. Lack of efficacy of twice-weekly urokinase in the prevention of complications associated with Hickman catheters: a multicentre randomised comparison of urokinase versus heparin.
Solomon B; Moore J; Arthur C; Prince HM
Eur J Cancer; 2001 Dec; 37(18):2379-84. PubMed ID: 11720831
[TBL] [Abstract][Full Text] [Related]
56. Managing dysfunctional central venous access devices: a practical approach to urokinase thrombolysis.
Kumwenda M; Dougherty L; Spooner H; Jackson V; Mitra S; Inston N
Br J Nurs; 2018 Jan; 27(2):S4-S10. PubMed ID: 29368572
[TBL] [Abstract][Full Text] [Related]
57. Mechanical and infective central venous catheter-related complications: a prospective non-randomized study using Hickman and Groshong catheters in children with hematological malignancies.
Biagi E; Arrigo C; Dell'Orto MG; Balduzzi A; Pezzini C; Rovelli A; Masera G; Silvestri D; Uderzo C
Support Care Cancer; 1997 May; 5(3):228-33. PubMed ID: 9176970
[TBL] [Abstract][Full Text] [Related]
58. High dose urokinase for restoration of patency of occluded permanent central venous catheters in hemodialysis patients.
Shavit L; Lifschitz M; Plaksin J; Grenader T; Slotki I
Clin Nephrol; 2010 Oct; 74(4):297-302. PubMed ID: 20875382
[TBL] [Abstract][Full Text] [Related]
59. Novel approach using antimicrobial catheters to improve the management of central line-associated bloodstream infections in cancer patients.
Chaftari AM; Kassis C; El Issa H; Al Wohoush I; Jiang Y; Rangaraj G; Caillouet B; Pravinkumar SE; Hachem RY; Raad II
Cancer; 2011 Jun; 117(11):2551-8. PubMed ID: 24048803
[TBL] [Abstract][Full Text] [Related]
60. Prevalence of Symptomatic and Asymptomatic Thrombosis in Pediatric Oncology Patients With Tunneled Central Venous Catheters.
Schoot RA; van de Wetering MD; Stijnen T; Tissing WJ; Michiels E; Abbink FC; Raphael MF; Heij HA; Zwaan M; Lieverst JA; Caron HN; van Ommen H;
Pediatr Blood Cancer; 2016 Aug; 63(8):1438-44. PubMed ID: 27128820
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
